<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01536275</url>
  </required_header>
  <id_info>
    <org_study_id>PEPaNIC</org_study_id>
    <secondary_id>2012-000811-10</secondary_id>
    <secondary_id>ML8052</secondary_id>
    <secondary_id>NL38772.000.12</secondary_id>
    <secondary_id>IWT-TBM 110685</secondary_id>
    <nct_id>NCT01536275</nct_id>
  </id_info>
  <brief_title>Early Versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit</brief_title>
  <acronym>PEPaNIC</acronym>
  <official_title>Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Paediatric Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sophia Kindergeneeskunde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stollery Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the PEPaNIC trial it is investigated whether withholding parenteral nutrition during the
      first week in critically ill children is beneficial, compared to the current standard of the
      early start of parenteral nutrition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of new infection during ICU stay</measure>
    <time_frame>during ICU stay and up to 90 days post-randomization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of ICU dependency (crude stay days and time to alive discharge from ICU)</measure>
    <time_frame>during ICU stay and up to 90 days post-randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>during ICU stay, hospital stay and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to alive discharge from hospital</measure>
    <time_frame>during hospital stay and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypoglycaemia during ICU stay</measure>
    <time_frame>during the intervention window up to day 8 post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to final weaning from mechanical respiratory support</measure>
    <time_frame>during ICU stay and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of liver dysfunction during ICU stay</measure>
    <time_frame>during ICU stay and up 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for haemodynamic support during ICU stay</measure>
    <time_frame>during ICU stay and up 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of new kidney injury during ICU stay</measure>
    <time_frame>during ICU stay and up 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of antibiotics treatment during ICU stay</measure>
    <time_frame>during ICU stay and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of readmissions to the ICU</measure>
    <time_frame>up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of calories delivered during the ICU stay and in subset markers of feeding intolerance</measure>
    <time_frame>during the intervention window of 8 days and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of inflammation such as C-reactive protein concentrations during ICU stay</measure>
    <time_frame>during ICU stay and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural and or functional differences in muscle tissue during ICU stay</measure>
    <time_frame>during ICU stay and up to 90 days post-randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biochemical, metabolic, endocrine, immunological, inflammatory and (epi)genetic markers on blood samples</measure>
    <time_frame>up to 4 years post-randomization</time_frame>
    <description>with healthy matched control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional and neurocognitive development</measure>
    <time_frame>up to 4 years post-randomization</time_frame>
    <description>with healthy matched control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health economy analysis</measure>
    <time_frame>during index hospitalization</time_frame>
    <description>total health care costs during hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1440</enrollment>
  <condition>Critical Illness</condition>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Early parenteral nutrition</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Parenteral nutrition supplements insufficient enteral nutrition from admission to ICU according to the current standard of care per center</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late parenteral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parenteral nutrition will be withheld during the first 7 days of ICU stay</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Late parenteral nutrition</intervention_name>
    <description>Withholding parenteral nutrition during the first 7 days of ICU stay</description>
    <arm_group_label>Late parenteral nutrition</arm_group_label>
    <other_name>Late PN</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients admitted to the PICU with a STRONGkids score of 2 points or more upon ICU
             admission

        Exclusion Criteria:

          -  Age of 17 years or older

          -  Patients with a DNR code at the time of ICU admission.

          -  Patients expected to die within 12 hours (=moribund patients).

          -  Patient readmitted to ICU after randomization to the PEPaNIC trial, more than 48 hours
             after the initial discharge

          -  Patients transferred from another paediatric intensive care after a stay of more than
             7 days

          -  Patients suffering from ketoacidotic or hyperosmolar coma on admission.

          -  Patients suffering from Short Bowel Syndrome on home PN or other conditions that
             require home PN

          -  Patients suspicious or established inborn metabolic diseases requiring specific diet

          -  STRONGkids score lower than 2 on ICU admission.

          -  Premature Newborns ( 37 weeks gestational age upon admission in the PICU)

          -  Prior inclusion in another randomized controlled outcome study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Greet Van den Berghe, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tom Fivez, MD</last_name>
    <phone>003216340989</phone>
    <email>tom.fivez@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dieter Mesotten, MD PhD</last_name>
    <phone>003216340977</phone>
    <email>dieter.mesotten@med.kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept Intensive Care Medicine</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Fivez, MD</last_name>
      <phone>003216340989</phone>
      <email>tom.fivez@uzleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Dieter Mesotten, MD PhD</last_name>
      <phone>003216340977</phone>
      <email>dieter.mesotten@med.kuleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Dieter Mesotten, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom Fivez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stollery Children's Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Erasmus MC Sophia Kinderziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sascha Verbruggen, MD, PhD</last_name>
      <phone>0031107036669</phone>
      <email>s.verbruggen@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Koen Joosten, MD, PhD</last_name>
      <phone>0031107040704</phone>
      <email>k.joosten@erasmusmc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.kuleuven.ac.be/english/index.htm</url>
    <description>Katholieke Universiteit Leuven Homepage</description>
  </link>
  <reference>
    <citation>Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011 Aug 11;365(6):506-17. doi: 10.1056/NEJMoa1102662. Epub 2011 Jun 29.</citation>
    <PMID>21714640</PMID>
  </reference>
  <reference>
    <citation>Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009 Feb 14;373(9663):547-56. doi: 10.1016/S0140-6736(09)60044-1. Epub 2009 Jan 26.</citation>
    <PMID>19176240</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2012</study_first_submitted>
  <study_first_submitted_qc>February 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2012</study_first_posted>
  <last_update_submitted>June 21, 2017</last_update_submitted>
  <last_update_submitted_qc>June 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Greet Van den Berghe</investigator_full_name>
    <investigator_title>Head of Dept Intensive Care Medicine</investigator_title>
  </responsible_party>
  <keyword>critical illness</keyword>
  <keyword>children</keyword>
  <keyword>nutrition</keyword>
  <keyword>metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

